These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9091810)

  • 21. Transmission of multidrug-resistant human immunodeficiency virus--the wake-up call.
    Cohen OJ; Fauci AS
    N Engl J Med; 1998 Jul; 339(5):341-3. PubMed ID: 9682050
    [No Abstract]   [Full Text] [Related]  

  • 22. [Perinatal maternal-infant transmission of human immunodeficiency virus and its prevention].
    Hang A
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):79-80. PubMed ID: 10923410
    [No Abstract]   [Full Text] [Related]  

  • 23. Current world literature.
    Curr Opin HIV AIDS; 2012 Jul; 7(4):376-81. PubMed ID: 22678490
    [No Abstract]   [Full Text] [Related]  

  • 24. A model for communitywide delivery of postexposure prophylaxis after potential sexual exposure to HIV.
    Roland ME
    Sex Transm Dis; 2007 May; 34(5):294-6. PubMed ID: 17308501
    [No Abstract]   [Full Text] [Related]  

  • 25. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
    AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New recommendations on health care worker exposure to HIV.
    Woodward J
    STEP Perspect; 1996; 8(3):8-10. PubMed ID: 11364268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
    Lurie P; Miller S; Hecht F; Chesney M; Lo B
    JAMA; 1998 Nov; 280(20):1769-73. PubMed ID: 9842953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV in pregnancy].
    Temmerman M
    Verh K Acad Geneeskd Belg; 2001; 63(5):493-510. PubMed ID: 11813506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
    Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Maternal factors and prevention of vertical HIV transmission].
    Bates Egam I
    Allergol Immunopathol (Madr); 1998; 26(3):120-2. PubMed ID: 9675393
    [No Abstract]   [Full Text] [Related]  

  • 32. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV postexposure prophylaxis after sexual assault.
    Stevens L; Brown MA
    Nurse Pract Forum; 2001 Dec; 12(4):192-8. PubMed ID: 11889687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sending HIV drugs to developing countries.
    Arboleda CH
    GMHC Treat Issues; 1998 Jun; 12(6):7-8. PubMed ID: 11365724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDC won't recommend non-occupational PET. Centers for Disease Control and Prevention.
    AIDS Alert; 1998 Feb; 13(2):17-8. PubMed ID: 11365035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.
    Sonder GJ; van den Hoek A; Regez RM; Brinkman K; Prins JM; Mulder JW; Veenstra J; Claessen FA; Coutinho RA
    Sex Transm Dis; 2007 May; 34(5):288-93. PubMed ID: 16980918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001.
    Harris NS; Fowler MG; Sansom SL; Ruffo N; Lampe MA
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S33-41. PubMed ID: 17825649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on vertical HIV transmission.
    Groginsky E; Bowdler N; Yankowitz J
    J Reprod Med; 1998 Aug; 43(8):637-46. PubMed ID: 9749412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary.
    Beyrer C
    Clin Infect Dis; 2007 Apr; 44(7):981-7. PubMed ID: 17342654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.